StockWatch
·
FIVE-STAR BUSINESS FINANCE · Q2 FY-2027 · PREVIEW

On Track for 20% AUM Growth—Watch for Disbursement Pace and Credit Cost Reversal

Five-Star's growth engine is running ahead of plan. Q1 FY27 delivered historical best disbursements despite seasonally weak quarter; the Street expects momentum to hold as NBFC credit demand remains strong. The debate: can the company sustain the 20% AUM growth guidance without margin compression from higher credit costs (1.7% guidance vs. historical ~1.3%)? And will the FII exit (down 1,415 bps in 5 quarters) continue?

Q2 FY27 resultsFIVESTARFive-Star Business Finance Ltd20 Oct 2026 · 3 min read

The Setup: Momentum Meets Margin Headwinds

Five-Star enters Q2 FY27 with clear momentum. Management is confident of ~20% AUM growth for the full year, with Q1 FY27 delivering 10% YoY expansion to ₹13,722 Cr—achieved despite being a seasonally weak quarter. Critically, disbursements hit a historical best in Q1, underpinning confidence in the guidance. The NBFC credit environment remains strong, and Five-Star's non-deposit funding model is well-positioned. The Street consensus target is ₹645–₹743, implying modest upside to the current price of ₹503.35, reflecting a Neutral rating and execution risks centered on profitability.

AUM growth (YoY)

~20%

Management guidance for FY27; Q1 FY27 tracked 10% (seasonally weak base)

Disbursements (quarterly)

~₹1,600–1,750 Cr

FY27 target ₹6,500–7,000 Cr (implying ~₹1.6–1.75k per quarter); Q1 was historical best

Credit cost guidance

1.7%

FY27 full-year guidance; higher than historical ~1.3%—a margin headwind

ROA target

~8.5%

FY27 guidance; medium-term (FY26–28) trajectory 7.0% (RoA) and 18–20% RoE

What Good vs. Weak Looks Like

A strong print would show AUM growth running at 20%+ YoY (or holding pace with Q1 10% QoQ), disbursements sustaining or beating the historical-best run-rate, and asset quality metrics holding steady or improving further (1+DPD <16%, 30+DPD <12%). Margin stabilization despite the higher 1.7% credit cost guidance would signal pricing power offsetting the cost rise. A weak print would flag slower disbursement velocity (below ₹1,500 Cr), AUM growth sliding below 20% YoY (e.g., reverting to <15%), deteriorating 1+DPD or 30+DPD metrics suggesting credit stress, or net interest margin compression beyond normal seasonality. Management commentary on whether the 1.7% credit cost guidance is tracking on-plan will be critical; if credit costs are running higher, net profitability could be squeezed even if AUM expands.

On Track for the Full-Year Guide?

Five-Star's FY27 targets appear achievable based on Q1 momentum, but execution is tightening. AUM growth: Q1 delivered 10% YoY; if Q2–Q4 maintain or accelerate that pace, 20% full-year is credible. Disbursements: Q1's historical best suggests the company has capacity to hit the ₹6,500–7,000 Cr FY27 range. However, profitability hinges on credit costs. The 1.7% FY27 guidance is notably higher than the company's historical average, reflecting a tighter credit environment and expected higher slippages. If actual credit costs exceed 1.7%, the ROA target (8.5% FY27) could be at risk. The company has signaled discipline through improved asset-quality metrics (1+DPD down 60 bps sequentially in Q1), so the Street is cautiously optimistic. Monitor whether management sounds confident on sustaining both growth AND profitability simultaneously, or if trade-offs emerge.

What the Street Says

Since Last Quarter: Filings & Signals

Notable Corporate Actions & Filings
  • 1 · Dividend Declared (July 2026)

    Board recommended ₹2.00 per share final dividend for FY26. Affirms shareholder-friendly stance, though payout ratio remains low at ~5%, suggesting scope for higher distributions if earnings scale.

  • 2 · Auditor Rotation (July 2026)

    M/s Suri & Co appointed as joint statutory auditors for 3 years (effective post-AGM). Routine governance; no operational impact flagged.

  • 3 · Board Composition: Director Transition (July 2026)

    Anand Raghavan completed his two 5-year terms as Independent Director. Sreeram Ranganathan Iyer appointed as new Independent Director. Routine board refresh; governance continuity maintained.

  • 4 · Trading Window (Closed as of Sep 28, 2026)

    Insider trading window closed in line with Q2 result announcement protocol. Standard regulatory compliance.

  • 5 · Ownership Shift (Trend Q1 FY26–Q1 FY27)

    FII steady exit: 58.12% → 43.97% (-1,415 bps over 5 quarters). DII accumulation: 9.48% → 22.35% (+1,287 bps). Narrative: FII profit-taking or rotation to higher-growth tech/pharma; DII (domestic mutual funds, insurers) adding on perceived value at current prices. Watch in Q2: further FII selling (which could weigh on sentiment) or stabilization (signaling domestic support).

Key Metrics to Watch on Oct 26

Result Day Focal Points
  • 1 · Consolidated AUM & QoQ Growth

    Expect disclosure of total AUM and sequential growth. If Q1 was 10% YoY on a seasonally weak base, Q2 (stronger seasonally) should be on-plan if the 20% FY27 trajectory is intact. Watch for any slowdown signals.

  • 2 · Disbursements & Sanction Pipeline

    Q1's historical best was the headline. Q2 should show whether that pace can sustain or whether it was front-loaded. Slowing disbursements (even if AUM grows) would signal tougher demand or tighter risk appetite. Management's pipeline guidance for H2 FY27 will be crucial.

  • 3 · Actual Credit Costs vs. 1.7% Guidance

    The ₹ crore provision for slippages / ECL (Expected Credit Loss) is the acid test. If actual is tracking 1.7% annualized, confidence in ROA 8.5% for FY27 remains intact. If running above, margin pressure looms. This is the swing factor for profitability and stock re-rating.

  • 4 · Net Interest Margin (NIM) & Cost-to-Income

    With higher credit costs and stronger competition, NIM may compress. Watch whether management has raised pricing or improved asset mix to offset. Cost-to-income under operating leverage should be a positive, but funding cost inflation could be a headwind.

  • 5 · Asset Quality Deep Dive (1+, 30+, 90+ DPD)

    Q1 showed improvement (1+DPD 16.7%, down 60 bps QoQ). Q2 is a seasonally stronger quarter. Expect further improvement or at least stability. Any deterioration would signal credit environment tightening and could flip sentiment.

The Takeaway

Five-Star enters Q2 FY27 with a clear tailwind: strong AUM growth momentum, improving asset quality, and a healthy NBFC credit cycle. Management's 20% AUM growth guidance is within reach, and disbursement capacity has been proven. The setup is constructive for a beat on volume. However, the Street's Neutral stance reflects genuine execution risk: the margin equation is under pressure from 1.7% credit cost guidance, and FII are exiting steadily. Expect management to emphasize both growth AND profitability discipline. Result day will pivot on three things: whether disbursement pace sustains (confirming demand strength), whether credit costs are tracking the 1.7% guide (confirming margin defensibility), and whether management's commentary signals confidence in 20% AUM growth for the full year without profit trade-offs. If all three align, the stock could re-rate upward; if credit costs overshoot or growth slows, the Neutral rating will hold.

Watch Oct 26 for: Consolidated AUM growth trajectory (pace and seasonality), disbursement run-rate (growth vs. historical trend), actual credit cost provisions (vs. 1.7% guidance), and management's full-year outlook confidence (or any moderation in growth/margin expectations).

Informational and educational content only. Not investment advice.